載入中
Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
最新資料
¥1,759
−¥273.5 · -13.46%
盤中時間採用JST。市場資料可能有所延遲。
Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
日內區間
目前¥1,759
52週區間
目前¥1,759
盤中時間採用JST。市場資料可能有所延遲。
Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
日內區間
目前¥1,759
52週區間
目前¥1,759
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（JPY） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 1.01兆 JPY | 9973.32億 JPY | 9257.52億 JPY | 8819.23億 JPY | 7501.23億 JPY |
| 銷貨成本 | 3565.86億 JPY | 3480.45億 JPY | 3421.19億 JPY | 3192.25億 JPY | 2741.31億 JPY |
| 毛利 | 6540.9億 JPY | 6492.87億 JPY | 5836.33億 JPY | 5626.98億 JPY | 4759.92億 JPY |
| 研究與開發 | 1099.48億 JPY | 849.59億 JPY | 807.27億 JPY | 768.66億 JPY | 853億 JPY |
| 銷售、一般及管理費用 | 3971.32億 JPY | 3761.8億 JPY | 3512.32億 JPY | 3093.62億 JPY | 2413.34億 JPY |
| 營業費用 | 5070.8億 JPY | 4632.49億 JPY | 4342.96億 JPY | 3862.28億 JPY | 3266.34億 JPY |
| 利息收入 | 61.71億 JPY | 32.95億 JPY | 23.61億 JPY | 37.02億 JPY | 10.13億 JPY |
| 利息支出 | 92.97億 JPY | 48.21億 JPY | 58.09億 JPY | 60.34億 JPY | 51.41億 JPY |
| 折舊和攤銷 | 672.16億 JPY | 664.56億 JPY | 659.4億 JPY | 667.41億 JPY | 646.15億 JPY |
| 營業利益 | 1470.1億 JPY | 1860.38億 JPY | 1493.37億 JPY | 1764.7億 JPY | 1493.58億 JPY |
| 淨利 | 681.72億 JPY | 1178.55億 JPY | 2425.66億 JPY | 1434.32億 JPY | 1157.42億 JPY |
公司資料更新於 2026年10月14日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
Next Funds Nikkei 225 ETF1321.T715.39億0.40%18.12兆 JPY0.08%¥706.4+0.04%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T660.19億0.19%35.17兆 JPY0.05%¥431.3-0.28%
Nikko Exchange Traded Index Fund 2251330.T354.79億0.40%8.84兆 JPY0.08%¥70,680+0.06%
iShares Core Nikkei 225 ETF1329.T85.84億0.39%2.17兆 JPY0.05%¥7,073+0.01%
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T65.94億0.28%2.37兆 JPY0.11%¥37,180+0.08%
iShares Core TOPIX ETF1475.T56.37億0.19%3.01兆 JPY0.05%¥425-0.21%
iShares JPX-Nikkei 400 ETF1364.T17.25億0.28%6176.33億 JPY0.05%¥3,822-0.08%
Vanguard Total International Stock ETFVXUS2.06億0.03%6657億 USD0.05%US$84.54+0.12%Next Funds Nikkei 225 ETF1321.TNEXT FUNDS TOPIX Exchange Traded Fund1306.TNikko Exchange Traded Index Fund 2251330.TiShares Core Nikkei 225 ETF1329.TNEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.TiShares Core TOPIX ETF1475.TiShares JPX-Nikkei 400 ETF1364.TVanguard Total International Stock ETFVXUSAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
